The 10th Adaptive Designs in Clinical Trials conference will once again be held in the UK. The two day SMi group event is based at the Copthorne Tara Hotel, Scarsdale Place, Kensington, London, on April 9th and 10th 2018. It features a varied and exciting schedule of speakers who are key figures in relevant clinical, research and pharmaceutical fields.
This valuable opportunity to learn about, explore and discuss a range of key aspects in the clinical trial field is particularly beneficial to statisticians and bi-statisticians, along with clinical scientists, trial directors, project managers and research advisors. Around a hundred delegates are expected to attend this event.
Just two minutes from a Tube station and offering plenty of onsite parking, the Copthorne Tara is an extremely convenient location for attendees using either personal or public transport. Alongside a spacious conference centre with business facilities, several eateries and bars, there is a fitness room and gift shop.
Both days begin with a 30-minute window for coffee and registration, followed by a short opening address by the chairman. Day one packs in seven 40 minute presentations, [Spotlight Sessions], morning coffee, and an hour for lunch and networking before an extended afternoon tea break at 3.20. The days ends with a presentation concerning clinical research programmes and a case study. Day 2 includes six presentations and a panel discussion.
There are also two half day workshops running on Wednesday April 11th, featuring Christopher Jenison from the University of Bath, who explores clinical trials and multiple hypothesis testing, and Berry Consulting’s Tom Parke whose topic is ‘Unlocking the Potential of Platform Trials’.
A range of approaches and issues are covered during the conference, crafted into a busy and varied schedule in a way which highlights everything from state of the art innovation utilising phone apps and the like in paid medical trials from companies such as http://www.trials4us.co.uk/, to emerging medical strategies and therapies. The EMA and MHRA share the most recent regulations regarding topics like ‘planning and assessing umbrella and basket trials’.
Adaptation is a skill which needs to be acknowledged, understood, tamed and mastered in the clinical trial field, especially as constant innovations in areas such as medicine, biotech and genomics add more information to this fast-moving field.